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INTRODUCTION
Alzheimer’s disease (AD) is the most common
form of degenerative dementia that affects a large
proportion of the elderly people with initial and
progressive symptoms of memory loss (1-3). The
most consistent findings in AD are degeneration
of the cholinergic cells in the nucleus basalis of
Meynert (NBM) and loss of the basal forebrain
cortical cholinergic innervation (4). Clinical studies
have suggested that the loss of cholinergic axons
may contribute to the cognitive deficits in AD. The
major cholinergic innervation to the cerebral cortex
originates from NBM. The pathological hallmarks of
AD are extracellular deposition of amyloid-β protein
(AP)senile plaques, and intracellular accumulation
of neurofibrillary tangles containing an abnormally
phosphorylated microtubule-associated protein, tau
(5). It is believed that the above-mentioned neuro-
pathological alterations affecting mainly the cholinergic
system cause dementia in AD patients. The currently
available therapeutic interventions mainly aim at
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alleviating the cholinergic deficits, but unfortunately,
these strategies do not prevent the disease, but instead
offer a limited symptomatic improvement (6).
Identification of the mammalian neural stem cells
(NSCs) has brought high expectations for the clinical
application of NSCs in the cell replacement therapeutic
procedures for the central nervous system disorders.
Recent studies have demonstrated that transplantation
of in vitro expanded neural progenitor cells (NPCs)
including NSCs in the animal models of several
neurological conditions, such as Parkinson’s disease
(PD), multiple sclerosis, traumatic and ischemic brain
injuries, resulting in functional recovery of the animals
to some extent (7-12). These data suggest that such
neural precursors might offer a useful future therapy
for AD. The embryonic stem cells (ES cells) were first
isolated from cultures of the mouse blastocysts ap-
proximately two decades ago (8). The ES cells give
rise to aggregates of cells that are termed embryoid
bodies (EBs). The EBs can change into various cell
types that are descendants of the three cardinal germ
layers of the embryo. Selective expansion of NSCs by
culture of the EBs in serum-free defined media with
fibroblast growth factor-2 (FGF-2) allows further
elaboration of neurospheres that can be specified to
become neurons by application of FGF-2 (11, 12).
In the present study, we tried to assess whether the
mouse embryonic stem cell(ES)-derived neurospheres
grafted in the prefrontal andparietal corticeshave effects
on the disruption of spatial memory and the impaired




The experimental protocol was approved by the
Institute of Laboratory Animal Sciences of Faculty of
Medicine of Kagawa University and conforms to the
National Institutes of Health guidelines for the care and
use of animals in research. 9-week-old adultmale C57
BL/6 mice weighing 20 to 22 g were used for all ex-
periments.
Experimental design
Five groups of mice were used for behavioral and
histological studies (1). NS transplantation group :
mice (n=10) received neurospheres transplantation
4 weeks after NBM lesion (2). ES transplantation group:
mice (n=6) receivedmouse embryonic stem cells (ES)
transplantation 4 weeks after NBM lesion(3). Lesioned
group:mice(n=14) were lesioned in the right NBM
(4). Sham lesioned control group:mice (n=12) were
given injection of vehicle (0.1 µl of 0.1 mmol PBS)
(5). Normal control group : age-matched mice (n=15)
received no manipulations were served as normal
controls.
NBM lesioning
Animals were anesthetized using a combination of
ketamine (60 mg/kg body weight; Bayer, Germany)
and xylazine (20mg/kg bodyweight ;Bayer,Germany)
in saline administered intraperitoneally. After being
fixed carefully in stereotaxic apparatus (Model SR-
6N, Narishige, Japan), the mouse’s scalp was cut, a
small craniotomy was drilled, and 0.5µg ibotenic acid
in 0.1µl of 0.1mmol phosphate-buffered saline (PBS)
was infused into each of two sites of right NBM (13)
(coordinates from bregma, midline, and dura, with
incisor bar+1 :A=-0.1, L=2.0, DV=4.2 ;A=-0.8, L=2.5,
DV=4.0 respectively through a glass capillary(inner
diameter～50µm) connected to a 2-µl Hamilton syringe
(Model 7102KH, Reno, NV). The infusion was made
over 3 minutes, retained 3 minutes, and retarded 3
minutes.
Neural stem cell culture
ES cell cultureMouse ES cell lines EB3 which has
one allele of Pou5f1 inactivated by targeted integration
of an IRESBSDpA cassette and transfected with GFP
gene were cultivated as described previously (14).
Briefly, the cells were maintained in the absence of
feeder cells in Glasgow minimal essential medium
(GMEM ; Sigma) supplementedwith 10%FCS(Equitech-
Bio Inc, Kerrville, TX), 1 mM sodium pyruvate, 10-4M
2-mercaptoethanol, 1×nonessential amino acids,
and 1,000 U of leukemia inhibitory factor (LIF) per ml
on gelatin-coated dishes. 5 µg/ml of blastcydineS
(Funakoshi, Tokyo, Japan) was further added for the
stem cell selection.
Differentiation of ES cells and selective amplification
and differentiation of neural progenitor cells
To induce differentiation of ES formation, a single
cell suspension of ES cells were plated onto non-
adeherent bacterial culture dishes at a density of 5×104
cell/ml inαMEM(GIBCO/Invitrogen) supplemented
with 10% FCS, 10-4M 2-mercaptoethanol. After EBs
formation 6 days later, a single suspension were got
by trypsinization for 5 minutes with 0.25% trypsin in
1 mM EDTA (GIBCO/Invitrogen), followed by
quenching with 10% FCS. The cells were washed
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twice with basic neurosphere medium composed
of DMEM:F12 (1:1), 0.6% glucose, 2mM glutamine,
3mM sodium bicarbonate, 5 mMHEPES buffer, 25µg/
ml insulin, 100µg/ml transferring, 20 nMprogesterone,
60µm putrescine, 30 nM selenium chloride ( all from
Sigma except glutamine from GIBCO/Invitrogen)
and plated onto T75 flasks (Greiner) at a density of
2×104 or 1×105 cells/ml in the neurosphere medium -
basic neurospheremedium supplementedwith 20 ng/
ml FGF 2 (Peprotech, Rocky Hill, NJ) and 2 µg/ml
heparin sulfate (Sigma). Cells were grown for 5 to 7
days and formed neurospheres. For in vitro differ-
entiation of NPCs, the neurospheres were plated onto
poly-L-ornithin coated dishes in the basic neurosphere
medium and cultured for 5 to 14 days (P0).
ES cells were taken for transplantation 3 days
after monolayer formation of ES and neurospheres
5 to 7 days of P0 neurospheres. ES cells were collected
by centrifugation at 800 rpm for 3 and resuspended
in the ES culture medium. NS cells were collected
by settling down for 15 minutes and resuspended in
the NS culture medium. Cell suspensionsweremade
at a density of 1-5×104 cells/µl and were kept on ice
to optimize cell viability.
Transplantation
Transplantation was conducted 4 weeks after NBM
lesionwhen the animalshad recovered from the surgery
and cholinergic deafferentation was complete (data
note shown). ES or NS cells were transplanted to
regions of frontal association cortex and barrel
field of S1 cortex stereotaxically. Glass capillary
(inner diameter～70µm)connected to a 2-µl Hamilton
syringe (Model 7102 KH, Reno, NV) were used to
introduce 50 nl of donor cells every 50µm at depths
from 600-100 µm from the pial surface (total 400 µl
per injection site )(13). Injection tracks spanned layers
II though VI. Each mouse received four injections
according to the following coordinates from bregma
and midline :A=3.2, L=1.4 ;A=2.7, L=1.6 ;A=-0.8, L =
3.2 ; A=-1.6, L=2.813. Mice did not receive immuno-
suppression therapy.
Behavioral Assessment
Eight-direction maze test was initiated 8 weeks after
transplantation and conducted as described elsewhere
(9). The radial maze consisted of 8 symmetrical arms
(25 cm long and 6 cm wide, with side walls 6 cm
high), radiating from an octagonal central platform
(10.5 cm diameter). The platform was enclosed by a
wall 6 cmhigh. The floor of themazewasmadeofwood
painted white, and the wall consisted of transparent
Plexiglas. The apparatus was elevated 50 cm above
the floor placed in a closed roomwhere all visual cues
were kept unchanged throughout the test trial. During
the experiment, the maze was maintained in a constant
orientation, and the experimenter stay constant position
beside the maze and observed the performances of
the mice. Completion of the radialmaze entailedmouse
running down and retrieving a food pellet of 15 mg
at the end of each arms. An arm entry was defined as
the crossing of the four paws into an arm. Before each
session of the test, mice were deprived of food until
their body weight was reduced to 80-85% of the initial
level. Pretraining started three days before test, in which
each animal was placed in the central platform and
allowed to explore and to consume a food pellet at the
endof eacharm.Thiswas repeateddaily for3consecutive
sessions. During the test trail, only 4 armswere baited
with food pellets and each mouse was given one daily
trail for 6d/week continued for 3 weeks. For each trial,
two parameters, reference memory error (entry into
the unbaited arms) andworkingmemory error (repeated
entry into the arms that had already been visited within
a trial) were measured.
Histology and Immunohistochemistry
One week after the completion of behavioral testing
(12 weeks after transplantation), all mice were
deeply anesthetized with ketamine and xylazine and
perfused transcardially with saline for 3 min and then
with ice-cold 4% paraformaldehyde(PFA) in 0.1 M
PBS (pH7.4) for 30min. Then, the brainswere removed
and placed in PFA overnight. 30µm thick Coronal or
sagittal sections were cut on a vibratome(D. S. K
microslicer, Japan) into series and placed free floating
in PBS at 4℃. Some sections of mouse brain trans-
planted with neurospheres or ES were stained by
HE. Adjacent series of sections were stained with
Hu C/D, ChAT, serotonin, glutamate decarboxylase
(GAD), GFP, glial fibrillary acidic protein (GFAP) ;
and double-stained with ChAT-AP, serotonin-AP,
ChAT-GFP, serotonin-GFP, GFAP-GFP. After extensive
rinsed in PBS during continuous oscillation, sections
were first incubated in 0.3% Triton X-100 for 5 min,
then in 10% normal goat serum for 30 min at room
temperature. This was followed by incubation in primary
antibodies diluted in 10% normal goat serum at 4 ℃
for 48 hr at the following dilutions : (1) rabbit polyclonal
anti-ChAT IgG (1:1000;Sigma);(2)rabbit polyclonal
anti-serotonin (1:5000;Sigma);(3) rabbit polyclonal
anti-GAD (1:1000;Chemicon); rabbit polyclonal anti-
GFAP (1:800;Sigma);(5) mouse monoclonal anti-AP
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(1 :50 ;Vector) ; (6) mouse monoclonal anti-GFP (1:
500;Molecular Probes);(7) mouse monoclonal anti-Hu
C/D (1:100;Molecular Probes). Sections were also
processedwith omission of primary antibodiesas negative
controls;therewas no nonspecific labeling. Sectionswere
rinsed four times with PBS and incubated with the
matching secondary antibodies conjugatedwith Alexa
at 4℃ overnight:(1) goat polyclonal anti-rabbit IgG
Alexa 11034 (1:1000;Molecular Probes) and (2) anti-
mouse IgG Alexa 11031(1 :1000;Molecular Probes).
Sections were subsequently rinsed four timeswithPBS
and mounted onto slides and coverslipped with Perma
Fluor Aqueousmountant (Immunotech,Marseille,France).
Fluorescent signals were detected and analyzed using
a confocal laser-scanningmicroscope LSM (Olympus,
Japan).
Statistics
The behavioral scores were analyzed using one-way
analysis of variance (ANOVA) and t-test. Values of
p<0.05 were considered significant. Values in graph
are expressed as mean±SEM.
RESULTS
Deafferentation of cholinergic system after ibotenic
acid NBM lesioning
There were many ChAT-positive neurons and
serotonin-positive neurons, and few GAD-positive
GABAergic neurons in NBM of the normal control
mouse (Fig.1a, e, i). In the prefrontal and parietal cortices
of the normal control mouse, many ChAT-positive
fibers, serotonin-positive axons and GAD-positive
neurons (Fig.1c, g, k) were recognized immuno-
histologically. In the NBM-lesioned mouse, the ChAT-
positive neurons, serotonin-positive neurons, and GAD-
positive neurons in the right NBM were reduced
in number, especially the ChAT-positive neurons
(Fig.1b, f, j). At the same time, the ChAT-positive fibers
in the prefrontal and parietal cortices decreased
remarkably, and the serotonin-positive axons slightly
(Fig.1d, h), alongwith highAP co-expression (Fig. 2a, b).
On the contrary, there were no changes in the GAD-
positive neurons in the cortex (Fig.1k, l).
Neurospheres survival and differentiation mainly into
cholinergic neurons after transplantation into the cortex
The neurospheres grafts survived in the trans-
plantation sites in the frontal and parietal cortices
and gave rise to numerous ChAT-positive cells within
and around the grafts as recognized by ChAT-GFP
double stain (Fig. 3a). Moreover, we could find a few
serotonin-positive cells (Fig. 3b), but neither GAD-
positive neurons nor GFAP-positive astrocytes were
recognized by GAD-GFP and GFAP-GFP double-
staining indicating no cellular differentiation from
the implanted neurospheres (Fig. 3c, d). The ChAT-
positive neurons and serotonin-positive neurons
migrated and integrated into the cortex around the
Fig. 1． Deafferentation of Cholinergic System after Ibotenic Acid NBM Lesioning
The ChAT+ neurons in right NBM (b vs. a) and ChAT+ fibers in right prefrontal cortex (d vs. c) were reduced obviously after ibotenic
acid NBM lesioning. The serotonin+ neurons in right NBM (f vs. e) and serotonin+ axons in right prefrontal cortex (h vs. g) decreased
slightly. There was no change of GAD+ neurons number in NBM (j vs. I) and prefrontal cortex (l vs. k). The relevant data of ChAT,
serotonin and GAD immunoreactivity in the parietal cortex were not shown..
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Fig. 2． Amyloid-βProtein (AP) Changes after NBM Lesion and Neurospheres Transplantation
There were heavy AP (red) productions surrounding ChAT+ (blue) fibers (a) and serotonin+ (blue) axons (b) in right prefrontal cortex
after NBM lesion. In the areas surrounding injection sites in prefrontal cortex, the ChAT+ neurons (c) and serotonin+ neurons (d)
differentiated from neurospheres expressed slight AP. The relevant data in the parietal cortex were not shown.
Fig. 3． Differentiation of Neurospheres and ES Cells after Grafted into Mouse Brain Cortex
There were a host of ChAT+ cells double stained by ChAT-GFP (a. ChAT, red; GFP, blue) and a very small number of serotonin+ cells
labeled by serotonin-GFP (b. serotonin, red; GFP, blue) within and surrounding the neurospheres grafts in the right prefrontal cortex.
GAD-GFP (c) and GFAP-GFP (d) double staining showed that the neurospheres produced no GABAergic (GAD+, red) neuron or GFAP+
(red) glia after transplanted into right prefrontal cortex. There were no Hu C/D-GFP (e) and GFAP-GFP (f) double stained cells in the
sites of ES grafts indicted that the ES cells could not differentiate into neurons (Hu C/D, red) or GFAP+ glias (GFAP, red) in right
prefrontal cortex. The relevant data in the parietal cortex were not shown.
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injection tract and expressed less AP (Fig. 2 c, d).
Development of ES cells after tansplantation into the cortex
The ES cells grafts formed teratomas in all injection
sites, with big ones in prefrontal cortex. Biopsy revealed
that teratoma was the cause of epilepsy in two mice
in our study. H&E staining revealed characteristics
of teratocarcinomas;namely, large tumor cells with
hypertrophic and dividing nuclei (Fig. 4b). In contrast,
the neurospheres developed into neuronswith normal
size and shape of the cell body and nucleus (Fig. 4a).
There was no neuronal or glia differentiation recog-
nized as Hu C/D-GFP or GFAP-GFP double labeling
immunoreactivity within and around the ES cells grafts.
Our results indicated that the implanted ES cells did
not migrate or differentiate, but proliferated into
teratocarcinoma in situ.
Eight-arm radial maze testing
Figure 5 shows themean scores ofworkingmemory
errors and referencememory errors on eight-arm radial
maze performance of all 5 groups of mice, with data
Fig. 4． HE Stain of Grafts of Neurospheres and ES Cells
HE stain revealed that neurospheres develop into neurons with normal size and shape of cell body and nuclear (a). In contrast, ES
cells grew into teratocarcinomas with large tumor cells having hypertrophic and dividing nucleus(b).
Fig. 5． Effects of Neurospheres and ES Cells on Eight-Arm Radial Maze Performance in Mice
Each column and vertical bar represents the mean±SEM of 18 trials. The statistical significance of injured group and neurospheres
group vs. normal group are shown : *p<0.01 ; ES group vs. injured group are shown : #p< 0.01.
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averaged from 18 trials. In the NBM-lesioned mice,
the working memory errors increased significantly
(t=6.13, p<0.001 vs. the control group). In the mice
transplanted with neurospheres, the scores were
restored (t=0.307, p > 0.05, vs. the control group).
With respect to the scores of mice transplanted with
ES cells, the working memory deteriorated re-
markably (t=5.95, p<0.001 vs. normal group;t= 6.46,
p<0.001 vs. the NBM-lesioned group). There were
no differences in the referencememory errors among
the 5 groups (P>0.05, F=0.1439, d. f.=4, 62).
DISCUSSION
The results of our present investigation indicate
that neurospheres transplanted into the prefrontal
and parietal cortices produced numerousChAT-positive
neurons and significantly increased the performance
level of the NBM-lesioned mice in the radial arm
maze.
AD is characterized by progressive deterioration
of memory and higher cortical functions that ultimately
results in total degradation of the intellectual and
mental activities. For nearly a quarter of century, the
cholinergic hypothesis of AD has been valid that states;
1. the cholinergic neurons in the basal forebrain are
severely affected during the course of the disease,
detectable both histopathologically by loss of neurons,
and neurochemically, by loss of the marker enzymes
for acetylcholine synthesis (ChAT) and degradation,
and 2. the resulting cerebral cholinergic deficit leads
to memory loss. TheNBM,which provides themajor
cholinergic input to the neocortex, undergoes profound
neuron loss in AD (15-16). In the neocortex, there is
a loss of cholinergic fibers and receptors and a decrease
of both ChAT and acetylcholinesterase enzyme activities
(15, 17). It was assumed that many neurotransmitter
systems, including the serotoninergic and GABAergic,
may be involved in the pathology of AD and dementia
model made by ibotenic acid lesion of NBM (2, 4,
18, 19). However, the outstanding pathologic findings
are cholinergic neurons loss in NBM and cholinergic
dysfunction in the frontal and parietal association
neocortex (19-21). In the present study, we found
that in the mouse prefrontal and dorsal parietal
cortices, there were many ChAT-positive fibers, which
is consistent with a previous study (22). After including
theNBM lesion, theChAT-positive terminals decreased
evidently. The change of the serotonin+ axons was
slight, and there was no change in the GAD-positive
immunostaining. Ibotenic acid caused more prominent
cholinergic neurons loss than it affected the sero-
toninergic and GABAergic (GAD+) neurons inNBM.
The interpretation of our results could be that the basal
forebrain cholinergic neurons appear to be signifi-
cantly more vulnerable for toxicity (16).
The current drug therapies and other interven-
tional approaches procedures for AD are still limited
(17, 23). We are fortunate that neuroreplacement therapy
is now available. Several recent studies have dem-
onstrated that NPCs can integrate into the healthy
host rodent brain in a cytoarchitecturally correct
manner and differentiate into neurons and/or glia in
a manner appropriate to the site of engrafment
(24, 25). ES cells are pluripotent cells isolated from the
inner cell mass of the preimplantation mouse blas-
tocyst, which can differentiate into all kinds of cells.
We have established a novel differentiation protocol
of the ES cells to generate neurospheres that have
forebrain characteristics via generatingmany functional
cholinergic neurons in vitro and in vivo as described
in the Materials and Methods. After transplantation
into the frontal association cortex and barrel field of
S1 cortex, the neurospheres differentiated mainly
into ChAT-positive neurons, and the latter migrated
into the surrounding cortex. We only found a few
serotonin-positive neurons, and could scarcely find
GFAP-positive glias within and around the grafts.
The memory deficit in AD, which is characterized
by recent memory disruption, has been attributed
to cholinergic dysfunction in the neocortex. In theory,
this memory loss would be ameliorated after the
cholinergic system is restored. In our study, we used
the partially (4 of 8) baited eight-arm radialmaze task
to evaluate the cognitive and mnemonic abilities in the
mice. The mice were trained for one trial a day to eat
pellet placed in the end of each baied arm, and the
working memory error in the normal control group
was nearly zero till the end of the trials. The effective
performance in this task was based on two kinds of
memory components;namely, working memory and
referencememory. The former is a kind of information
which incorporates the chosen arms in that trial and
this disappears in a short time, and the latter is a kind
of information about the configuration of the extra-maze
(mainly visual) stimuli and should be retained until
the next trial. The prefrontal and parietal association
cortices, themajor target areas of forebrain cholinergic
neurons, have long been associated with high-level,
“executive”processes, particularly a form of short-
term information storage described as“working”memory
(26, 27). So, the working memory represents the current
spatial memory. Our results revealed that the ibotenic
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acid-induced NBM lesion produced significant dis-
ruption of the working memory, which is consistent
with another report (28). The transplanted neurospheres
led to improvement of the working memory decline.
The interpretation of this dramatic effect may be that
the newly formed cholinergic neurons from the
neurospheres grafts compensated for the cholinergic
deficits in the NBM-lesioned mice.
Two reports state that the naive ES cells develop
into dopaminergic neurons and cause behavioral
restoration when grafted in low numbers into the
striatum in a Parkinson rat model (29, 30). Another
report indicated that the ES cells differentiated into
neurons in the border zone of the ischemic lesion
after being transplanted into the rat brain, meanwhile
the ES cells produced highly malignant teratocar-
cinomas at the site of implantation without migra-
tion when grafted into the stroke mouse model
(7). These different outcomes between xenotrans-
plantation and homologous transplantation raise
concerns about the safety of ES cells transplantation.
Our results indicated that, the undifferentiated ES
cells produced malignant teratomas in all implanted
sites after being grafted into the mouse brain, with
big ones in the prefrontal area, and that the working
memory errors increased significantly as compare to
the NBM-lesioned group.
CONCLUSIONS
Neurospheres can differentiated into the cholinergic
neurons and restore the working memory decline
after transplanted in a Alzheimer mouse model. In
contrast, the transplantation of undifferentiated ES
cells did not give any effect to the memory deficit of
the NBM-lesioned mouse, but resulted in memory
deteriorated due to the tumor formation.
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